annual EBIT:
-$112.22M+$117.09M(+51.06%)Summary
- As of today (August 31, 2025), ARQT annual earnings before interest & taxes is -$112.22 million, with the most recent change of +$117.09 million (+51.06%) on December 31, 2024.
- During the last 3 years, ARQT annual EBIT has risen by +$94.13 million (+45.62%).
- ARQT annual EBIT is now -2633.17% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$14.61M+$9.92M(+40.43%)Summary
- As of today (August 31, 2025), ARQT quarterly earnings before interest & taxes is -$14.61 million, with the most recent change of +$9.92 million (+40.43%) on June 30, 2025.
- Over the past year, ARQT quarterly EBIT has increased by +$35.47 million (+70.82%).
- ARQT quarterly EBIT is now -145.44% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$85.84M+$35.47M(+29.24%)Summary
- As of today (August 31, 2025), ARQT TTM earnings before interest & taxes is -$85.84 million, with the most recent change of +$35.47 million (+29.24%) on June 30, 2025.
- Over the past year, ARQT TTM EBIT has increased by +$93.93 million (+52.25%).
- ARQT TTM EBIT is now -1015.50% below its all-time high of -$7.70 million, reached on September 1, 2018.
Performance
ARQT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ARQT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.1% | +70.8% | +52.3% |
| 3 y3 years | +45.6% | +77.8% | +66.6% |
| 5 y5 years | -160.2% | +59.0% | +6.6% |
ARQT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.1% | -91.4% | +86.0% | at high | +72.8% |
| 5 y | 5-year | -160.2% | +62.1% | -91.4% | +86.0% | at high | +72.8% |
| alltime | all time | -2633.2% | +62.1% | -145.4% | +86.0% | -1015.5% | +72.8% |
ARQT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$14.61M(-40.4%) | -$85.84M(-29.2%) |
| Mar 2025 | - | -$24.53M(+221.4%) | -$121.30M(-5.5%) |
| Dec 2024 | -$112.22M(-51.1%) | -$7.63M(-80.5%) | -$128.40M(-29.4%) |
| Sep 2024 | - | -$39.07M(-22.0%) | -$181.93M(+1.2%) |
| Jun 2024 | - | -$50.08M(+58.4%) | -$179.77M(-8.5%) |
| Mar 2024 | - | -$31.62M(-48.3%) | -$196.46M(-18.5%) |
| Dec 2023 | -$229.31M(-22.5%) | -$61.17M(+65.8%) | -$241.10M(-2.9%) |
| Sep 2023 | - | -$36.90M(-44.7%) | -$248.36M(-21.5%) |
| Jun 2023 | - | -$66.76M(-12.5%) | -$316.20M(+0.3%) |
| Mar 2023 | - | -$76.27M(+11.5%) | -$315.26M(+4.5%) |
| Dec 2022 | -$295.81M(+43.3%) | -$68.42M(-34.7%) | -$301.63M(-0.9%) |
| Sep 2022 | - | -$104.75M(+59.1%) | -$304.49M(+18.6%) |
| Jun 2022 | - | -$65.83M(+5.1%) | -$256.82M(+10.2%) |
| Mar 2022 | - | -$62.63M(-12.1%) | -$233.07M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$206.36M(+52.1%) | -$71.29M(+24.9%) | -$206.53M(+22.0%) |
| Sep 2021 | - | -$57.08M(+35.6%) | -$169.31M(+12.5%) |
| Jun 2021 | - | -$42.08M(+16.6%) | -$150.53M(+4.5%) |
| Mar 2021 | - | -$36.09M(+5.9%) | -$144.08M(+5.4%) |
| Dec 2020 | -$135.68M(+214.6%) | -$34.06M(-11.1%) | -$136.65M(+18.2%) |
| Sep 2020 | - | -$38.30M(+7.5%) | -$115.58M(+25.7%) |
| Jun 2020 | - | -$35.63M(+24.3%) | -$91.92M(+41.8%) |
| Mar 2020 | - | -$28.65M(+120.5%) | -$64.83M(+50.3%) |
| Dec 2019 | -$43.13M(+118.6%) | -$12.99M(-11.3%) | -$43.13M(+19.5%) |
| Sep 2019 | - | -$14.65M(+71.6%) | -$36.09M(+23.9%) |
| Jun 2019 | - | -$8.54M(+22.8%) | -$29.14M(+41.4%) |
| Mar 2019 | - | -$6.95M(+16.8%) | -$20.60M(+50.9%) |
| Dec 2018 | -$19.73M(+380.6%) | -$5.95M(-22.6%) | -$13.65M(+77.4%) |
| Sep 2018 | - | -$7.70M | -$7.70M |
| Dec 2017 | -$4.11M | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual EBIT year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly EBIT year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM EBIT year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of ARQT is -$112.22M
What is the all time high annual EBIT for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual earnings before interest & taxes is -$4.11M
What is Arcutis Biotherapeutics, Inc. annual EBIT year-on-year change?
Over the past year, ARQT annual earnings before interest & taxes has changed by +$117.09M (+51.06%)
What is Arcutis Biotherapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ARQT is -$14.61M
What is the all time high quarterly EBIT for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$5.95M
What is Arcutis Biotherapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, ARQT quarterly earnings before interest & taxes has changed by +$35.47M (+70.82%)
What is Arcutis Biotherapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ARQT is -$85.84M
What is the all time high TTM EBIT for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM earnings before interest & taxes is -$7.70M
What is Arcutis Biotherapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, ARQT TTM earnings before interest & taxes has changed by +$93.93M (+52.25%)